Market Cap

Opiant Pharmaceuticals, Inc. Market Capitalization:

$107.5 Million

USD as of Jan. 1, 2023

business Opiant Pharmaceuticals, Inc. Company Profile

Opiant Pharmaceuticals, Inc. Main Stock Listing

NASDAQ: OPNT

Market Capitalization History of Opiant Pharmaceuticals, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $622.07 B
Vertex Pharmaceuticals Incorporated $121.36 B
Regeneron Pharmaceuticals, Inc. $115.11 B
CSL Limited $95.75 B
Marinomed Biotech AG $75.67 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Opiant Pharmaceuticals, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2023 $107.5 M -18.17%
Jan. 1, 2022 $131.4 M 132.90%
Jan. 1, 2021 $56.4 M -13.95%
Jan. 1, 2020 $65.6 M -20.06%
Jan. 1, 2019 $82.0 M -24.46%
Jan. 1, 2018 $108.6 M 147.31%
Jan. 1, 2017 $43.9 M -16.50%
Jan. 1, 2016 $52.6 M 179.33%
Jan. 1, 2015 $18.8 M 5866.68%
Jan. 1, 2014 $315,502 -25.00%
Jan. 1, 2013 $420,669 33.33%
Jan. 1, 2012 $315,502 -85.71%
Jan. 1, 2011 $2.2 M -32.26%
Jan. 1, 2010 $3.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Opiant Pharmaceuticals, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Opiant Pharmaceuticals, Inc. has the following listings and related stock indices.


Stock: NASDAQ: OPNT

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.